Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Cosmax USA, Inc.
EIR
•Cosmax USA, Inc.•July 22, 2022

Cosmax USA, Inc. – FDA EIR, Jul 22, 2022

Record Details

An FDA inspection of CosMax USA, Inc. in Solon, OH, conducted from July 18-22, 2022, served as a follow-up to a previous warning letter. The inspection primarily focused on drug manufacturing operations, specifically cosmetics and sunscreens, and assessed the company's adherence to drug manufacturing regulations, particularly 21 CFR §211.160(b) concerning laboratory controls. The inspection identified a significant deficiency, resulting in a single observation on Form FDA 483. CosMax USA, Inc. was cited for using laboratory methods for stability testing that were not scientifically sound or proven to be stability-indicating. This included methods used for sunscreen products, a repeat observation from the prior inspection, indicating a persistent issue in ensuring product quality and purity over time. Additionally, inspectors verbally communicated a concern regarding incomplete manufacturing records, specifically the absence of all labeling specimens in packaging batch records for a specific SPF 30 lot. Company management acknowledged the observations and committed to implementing necessary corrective actions. They also pledged to submit a comprehensive written response addressing these findings within 15 business days of the inspection's conclusion.

Company
Cosmax USA, Inc.
Inspection date
July 22, 2022
Product type
drugs
Office
Food and Drug Administration
People
  • Jacob G. Lutz (Investigator)
  • Joohi Castelvetere
  • Euitak Kim (recipient)
  • Darlene Dieudonne (recipient)
  • Jeffrey Stoops (company_representative)
View Company Profile

ID · 45ca2bbe-2e22-47a3-b64d-2a1be92d06d8

Violation Codes3
21 CFR 211.160(b)21 CFR 820.19821 CFR 820.100

Full citation text and observation details available on the Dashboard.

Other documents for Cosmax USA, Inc.
  • 483 - 2025-09-12September 12, 2025
  • WARNING_LETTER - 2020-03-17March 17, 2020
  • 483 - 2017-09-20September 20, 2017
  • 483 - 2014-12-22December 22, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cosmax USA, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.